Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 44731 AL 44745

A new horizon for the anesthetic drug dyclonine

Bailly C.

Biochem Pharmacol. 2026 Feb;244:117569. doi: 10.1016/j.bcp.2025.117569. Epub 2025 Nov 28.

Multiple system atrophy related neurogenic bladder: mechanism and treatment

Ren G, Wang Y, Tian H, Zhang K, Zhang H, Liu X, Chen Z.

Neurol Sci. 2025 May;46(5):1965-1976. doi: 10.1007/s10072-025-08002-3. Epub 2025 Jan 29.

An autopsy case of coexisting spinal and bulbar muscular atrophy and multiple system atrophy

Miura M, Shintaku H, Numasawa Y, Ozaki K, Kanouchi T, Ishikawa K, Yokota T.

Neuropathology. 2025 Aug;45(4):e13031. doi: 10.1111/neup.13031. Epub 2025 Feb 6.

Neurodegeneration and the immune system: lessons from autoimmune encephalitis

Campetella L, Smolik K, Farina A, Joubert B, Muñiz-Castrillo S, Desestret V, Honnorat J.

J Neurol. 2025 Apr 24;272(5):359. doi: 10.1007/s00415-025-13094-0.

Islands and Neurology: An Exploration into a Unique Association

Dhar D, Mm S, Parvin N, Dey T, Pal A, Pal PK.

Neuroscientist. 2025 Aug;31(4):336-348. doi: 10.1177/10738584241257927. Epub 2024 Jun 6.

Parkinson's Spectrum Mechanisms in Pregnancy: Exploring Hypothetical Scenarios for MSA in the Era of ART

Kovacevic D, Velikic G, Maric DM, Maric DL, Puletic M, Gvozdenovic L, Vojvodic D, Supic G.

Int J Mol Sci. 2025 Apr 3;26(7):3348. doi: 10.3390/ijms26073348.

Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy

George NP, Kwon M, Jang YE, Kim SG, Hwang JS, Lee SS, Lee G.

Cells. 2025 Feb 12;14(4):265. doi: 10.3390/cells14040265.

Ethnic and Epidemiological Peculiarities of Movement Disorders across the World

Moura J, Balint B, Cullinane P, Alhashash H, Magrinelli F, Latorre A, Bhatia KP.

Mov Disord Clin Pract. 2025 Dec 18. doi: 10.1002/mdc3.70475. Online ahead of print.

Emerging Approaches to Mitigate Neural Cell Degeneration with Nanoparticles-Enhanced Polyelectrolyte Systems

Kwiatkowska A, Grzeczkowicz A, Lipko A, Kazimierczak B, Granicka LH.

Membranes (Basel). 2025 Oct 14;15(10):313. doi: 10.3390/membranes15100313.

An Apparently Isolated Optic Neuropathy Associated with Biallelic Variants in SLC25A46 Gene Encoding the Mitochondrial Ugo1-Like Protein

Reynier P, Amati-Bonneau P, Desquiret-Dumas V, Ferré M, Gueguen N, Plouzennec S, Michel M, Chevrollier A, Pegat A, Orssaud C.

Neuroophthalmology. 2025 Nov 3;50(1):96-100. doi: 10.1080/01658107.2025.2581675. eCollection 2026.

Elevated serum autotaxin levels and multiple system atrophy-like presentation in a patient with PLA2G6-associated neurodegeneration

Okubo S, Matsukawa T, Kawamoto N, Tsujita M, Orimo K, Naruse H, Mitsui J, Hamada M, Satake W, Toda T.

J Hum Genet. 2025 Jul;70(7):381-384. doi: 10.1038/s10038-025-01342-0. Epub 2025 Apr 22.

Systemic delivery of anti-sense oligonucleotide targeting a-synuclein for the treatment of multiple system atrophy

Spencer B, Quach B, Salehi S, Rissman RA.

Res Sq [Preprint]. 2025 Nov 7:rs.3.rs-7908950. doi: 10.21203/rs.3.rs-7908950/v1.

Supranuclear Vertical Gaze Palsy in Movement Disorders

Salari M, Alikhani A, Hojjati Pour F, Etemadifar M.

Neuroophthalmology. 2024 Jul 17;49(1):17-34. doi: 10.1080/01658107.2024.2379423. eCollection 2025.

Mitochondria-Mediated Mechanisms of Ferroptosis in Neurological Diseases

Zhong R, Yang H, Li X, Wang F, Zhai L, Gao J.

Neurochem Res. 2025 Nov 10;50(6):354. doi: 10.1007/s11064-025-04605-6.

Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy

Tohge R, Utsumi K, Miki K, Wang C, Oki M, Fujii C, Kondo T.

Cureus. 2025 Dec 14;17(12):e99224. doi: 10.7759/cureus.99224. eCollection 2025 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias